XOMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Feb 2017)
What this means for you
This application is over — abandoned 20 Feb 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86862262
- Mark type
- Design + words
- Filed
- 30 Dec 2015
- Published for opposition
- 24 May 2016
- Abandoned
- 20 Feb 2017
Goods and services
- Class 005 — Pharmaceuticals: Monoclonal antibodies for medical purposes; pharmaceuticals for the treatment of inflammatory, autoimmune, cardiovascular, metabolic, dermatologic, ophthalmologic, and infectious diseases and conditions; pharmaceuticals for the prevention and treatment of oncological, neurologic, gastroenteric, and infectious diseases and conditions; pharmaceutical preparations and substances for the prevention and treatment of viral, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, respiratory, hormonal, psychiatric, and immune system related diseases and conditions; ophthalmological preparations; anti-arthritic compositions and preparations
Owner
- XOMA (US) LLC, Berkeley, CA, US
- XOMA (US) LLC, Berkeley, CA, US
Prosecution history
- 06 Jan 2023 — WITHDRAWAL OF ATTORNEY GRANTED
- 06 Jan 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 21 Feb 2017 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 20 Feb 2017 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Jul 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 May 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 May 2016 — PUBLISHED FOR OPPOSITION
- 04 May 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Apr 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Apr 2016 — ASSIGNED TO EXAMINER
- 12 Jan 2016 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 09 Jan 2016 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Jan 2016 — NEW APPLICATION ENTERED